dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Grau Lopez, Lara |
dc.contributor.author | Marcos Fosch, Cristina |
dc.contributor.author | Daigre Blanco, Constanza |
dc.contributor.author | Palma Alvarez, Raul Felipe |
dc.contributor.author | Perea Ortueta, Marta |
dc.contributor.author | Rodríguez Frias, Francisco |
dc.contributor.author | Martinez Luna, Nieves Gudelia |
dc.contributor.author | Riveiro Barciela, Maria del Mar |
dc.contributor.author | Ramos Quiroga, José Antonio |
dc.contributor.author | Esteban Mur, Rafael |
dc.contributor.author | Rando Segura, Ariadna |
dc.contributor.author | Buti Ferret, Maria |
dc.contributor.author | Llaneras Artigues, Jordi |
dc.date.accessioned | 2022-05-02T12:27:53Z |
dc.date.available | 2022-05-02T12:27:53Z |
dc.date.issued | 2021-01-01 |
dc.identifier.citation | Grau-López L, Marcos-Fosch C, Daigre C, Palma-Alvarez RF, Rando-Segura A, Llaneras J, et al. Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management: Therap Adv Gastroenterol. 2021 Jan 1;14:1–13. |
dc.identifier.issn | 1756-2848 |
dc.identifier.uri | https://hdl.handle.net/11351/7426 |
dc.description | Virus de l'Hepatitis C; Diagnòstic dual; Trastorn per consum de substàncies |
dc.description.sponsorship | This work was supported by AbbVie. |
dc.language.iso | eng |
dc.publisher | SAGE Publications |
dc.relation.ispartofseries | Therapeutic Advances in Gastroenterology;14 |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Hepatitis C |
dc.subject | Malalties mentals |
dc.subject | Abús de substàncies |
dc.subject.mesh | Hepatitis C |
dc.subject.mesh | Substance-Related Disorders |
dc.subject.mesh | Outcome and Process Assessment (Health Care) |
dc.title | Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1177/17562848211016563 |
dc.subject.decs | hepatitis C |
dc.subject.decs | trastornos relacionados con sustancias |
dc.subject.decs | evaluación de resultados y procesos (atención a la salud) |
dc.relation.publishversion | https://doi.org/10.1177/17562848211016563 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Grau-López L, Daigre C, Palma-Alvarez RF, Perea-Ortueta M, Martínez-Luna N, Ramos-Quiroga JA] Secció d'Addicció i Diagnòstic Dual, Servei de Psiquiatria, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Psiquiatria, Salut Mental i Addiccions, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Biomedical Network Research Centre on Mental Health (CIBERSAM), Spain. Departament de Psiquiatria i Medicina Forense, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Marcos-Fosch C] Unitat del Fetge, Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Rando-Segura A, Rodriguez-Frias F] Laboratori de Malalties Hepàtiques-Hepatitis Viral, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Llaneras J] Unitat del Fetge, Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Riveiro-Barciela M, Esteban R, Buti M] Unitat del Fetge, Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain |
dc.identifier.pmid | 34471422 |
dc.identifier.wos | 000694027000001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |